Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AnaptysBio Inc.
DescriptionAnti-IL-36 receptor antagonist antibody
Molecular Target Interleukin-36 receptor antagonist (IL-36RA) (IL36RN)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationPsoriasis
Indication DetailsTreat generalized pustular psoriasis (GPP); Treat palmo-plantar pustular psoriasis (PPP)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today